Clinico-immunological effectiveness of immunotherapy in patients with respiratory syncytial virus infection

Abstract

We studied 44 patients with different complications of respiratory syncytial virus infection (bronchitis, acute tonsillitis, pneumonia). 29 patients were treated by recombinant interferon-α2b in the form of rectal suppositories (Viferon) as an addition medication to a common therapy. The results of clinical and immunological analysis showed that use of interferon in case of bronchitis or acute tonsillitis may be unreasonable, but it had relative indications in case of pneumonia

Keywords

• вирусная респираторная инфекция
• интерферон α2b